Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 27Genitourinary 5Lymphoid 4Gastrointestinal 4Head & Neck 3Gynecologic 3Dermatologic 3CNS 3Breast 3Thoracic 2Other hematologic neoplasm 2Other solid neoplasm 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 851Lung Neoplasms 575Small Cell Lung Carcinoma 164Colorectal Neoplasms 130Breast Neoplasms 104Melanoma 100Neoplasms 91Ovarian Neoplasms 89Neoplasm Metastasis 82Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 68Stomach Neoplasms 59Carcinoma, Renal Cell 54Head and Neck Neoplasms 53Esophageal Neoplasms 48Triple Negative Breast Neoplasms 47Endometrial Neoplasms 47Prostatic Neoplasms 45Uterine Cervical Neoplasms 41Colonic Neoplasms 40Urinary Bladder Neoplasms 39Mesothelioma 38Carcinoma, Hepatocellular 35Mesothelioma, Malignant 34Brain Neoplasms 30Sarcoma 28Carcinoma, Transitional Cell 28Adenocarcinoma of Lung 28Lung Diseases 24Disease 24

Interventions

liposomal doxorubicin 1Taxes 1Paclitaxel 1Lomustine 1Irinotecan 1Gemcitabine 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × Thoracic × 90 days × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡